PE20142279A1 - Composiciones de accion prolongada - Google Patents

Composiciones de accion prolongada

Info

Publication number
PE20142279A1
PE20142279A1 PE2014001416A PE2014001416A PE20142279A1 PE 20142279 A1 PE20142279 A1 PE 20142279A1 PE 2014001416 A PE2014001416 A PE 2014001416A PE 2014001416 A PE2014001416 A PE 2014001416A PE 20142279 A1 PE20142279 A1 PE 20142279A1
Authority
PE
Peru
Prior art keywords
long
term action
oil
action compositions
compositions
Prior art date
Application number
PE2014001416A
Other languages
English (en)
Inventor
Alawi Fadil Al
Karthigeyan Nanjan
Original Assignee
Bayer New Zealand Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49161532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20142279(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd
Publication of PE20142279A1 publication Critical patent/PE20142279A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE REFIERE A UNA COMPOSICION DE ACCION PROLONGADA QUE COMPRENDE UNA CANTIDAD TERAPEUTICAMENTE EFICAZ DE UN AGENTE BIOACTIVO, QUE ES UN COMPUESTO ANTIHELMINTICO QUE SE SELECCIONA DEL GRUPO DE AVERMECTINA, MOXIDECTINA, ENTRE OTROS; UN PORTADOR NO ACUOSO, QUE SE SELECCIONA DE ACEITE DE MAIZ, ACEITE DE MANI, ENTRE OTROS; Y UN SISTEMA SOLVENTE QUE COMPRENDE ACEITE DE RICINO Y AL MENOS UNA AMIDA CICLICA QUE ES UNA PIRROLIDONA.
PE2014001416A 2012-03-13 2013-03-13 Composiciones de accion prolongada PE20142279A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ59875712 2012-03-13

Publications (1)

Publication Number Publication Date
PE20142279A1 true PE20142279A1 (es) 2015-01-25

Family

ID=49161532

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014001416A PE20142279A1 (es) 2012-03-13 2013-03-13 Composiciones de accion prolongada

Country Status (20)

Country Link
US (1) US9616044B2 (es)
EP (1) EP2825154A4 (es)
JP (1) JP6273252B2 (es)
KR (1) KR20140136005A (es)
CN (1) CN104168886A (es)
AU (1) AU2013201479C1 (es)
CA (1) CA2867079A1 (es)
CL (1) CL2014002401A1 (es)
CO (1) CO7071132A2 (es)
CR (1) CR20140423A (es)
DO (1) DOP2014000207A (es)
IL (1) IL234597A0 (es)
MX (1) MX354966B (es)
NI (1) NI201400106A (es)
PE (1) PE20142279A1 (es)
PH (1) PH12014502016B1 (es)
RU (1) RU2014141088A (es)
SV (1) SV2014004804A (es)
WO (1) WO2013137748A1 (es)
ZA (1) ZA201406753B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
ATE180671T1 (de) * 1991-09-30 1999-06-15 Merck & Co Inc Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
KR100277287B1 (ko) 1995-09-25 2001-01-15 맨슨 하비 콜린 거대환 락톤 구충제 조성물
DE19613972A1 (de) 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6998131B2 (en) * 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
GB9815801D0 (en) * 1998-07-21 1998-09-16 Merck & Co Inc Liquid polymeric compositions for controlled released bioactive substances
CN1130990C (zh) 1999-11-02 2003-12-17 王毅远 一种纯天然方便食品及其制造方法
US6340672B1 (en) 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AU781682B2 (en) 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
CN1383821A (zh) 2001-03-16 2002-12-11 王玉万 一种含丙硫苯咪唑亚砜或其盐类的兽用注射剂
AU2002100152A4 (en) * 2002-02-28 2002-04-11 Jurox Pty Ltd Parasiticide composition
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
CN1490009A (zh) * 2002-10-17 2004-04-21 王玉万 含抗球虫药物的缓释注射剂
ES2341543T3 (es) * 2003-05-19 2010-06-22 Nippon Soda Co., Ltd. Composicion insecticida.
NZ535644A (en) 2003-07-25 2007-05-31 Ashmont Holdings Ltd Anthelmintic formulations
CN1293921C (zh) 2003-08-18 2007-01-10 王玉万 含乙基纤维素和脂肪酸酯类的长效注射剂
NZ546340A (en) 2003-10-17 2009-08-28 Intervet Int Bv Compositions for controlling parasites comprising a combination of abamectin and ivermectin
AU2005100403B4 (en) * 2005-05-13 2005-09-01 Jurox Pty Ltd Parasiticide Composition
BRPI0800259A2 (pt) * 2008-02-27 2011-05-31 Noxon Do Brasil Quimica E Farmaceutica Ltda formulações veterinárias compreendendo lactonas macrocìclicas e minerais, seus usos na preparação de produtos veterinários e métodos de ganho de produtividade e tratamento e/ou profilaxia de doenças causadas por agentes biológicos nocivos à saúde animal
WO2010008891A2 (en) 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
EP2396006B1 (en) * 2009-02-16 2012-12-19 Pfizer Inc. High dosage doramectin formulation
CN101703776B (zh) * 2009-09-28 2012-07-11 洛阳惠中兽药有限公司 一种抗感染剂长效注射液的制备方法
BRPI1001224A2 (pt) 2010-04-07 2011-03-15 Clarion Biociencias Ltda processo de fabricação de formulação injetável a base de fluazuron associado a avermectinas para o controle e prevenção de endo e ectoparasitas em animais domésticos
EP2658541B1 (en) * 2010-12-27 2022-01-26 Intervet International B.V. Topical localized isoxazoline formulation comprising glycofurol

Also Published As

Publication number Publication date
IL234597A0 (en) 2014-11-30
JP6273252B2 (ja) 2018-01-31
PH12014502016A1 (en) 2014-11-24
US20150038565A1 (en) 2015-02-05
PH12014502016B1 (en) 2014-11-24
EP2825154A1 (en) 2015-01-21
NI201400106A (es) 2015-01-14
KR20140136005A (ko) 2014-11-27
MX2014010957A (es) 2014-10-13
CO7071132A2 (es) 2014-09-30
CL2014002401A1 (es) 2015-04-17
AU2013201479C1 (en) 2017-11-09
RU2014141088A (ru) 2016-05-10
EP2825154A4 (en) 2015-11-11
WO2013137748A1 (en) 2013-09-19
CR20140423A (es) 2014-10-20
US9616044B2 (en) 2017-04-11
SV2014004804A (es) 2017-04-20
ZA201406753B (en) 2015-12-23
AU2013201479B2 (en) 2015-07-02
CA2867079A1 (en) 2013-09-19
DOP2014000207A (es) 2014-11-30
JP2015509978A (ja) 2015-04-02
CN104168886A (zh) 2014-11-26
AU2013201479A1 (en) 2013-10-03
MX354966B (es) 2018-03-27

Similar Documents

Publication Publication Date Title
NI201400842A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas.
CL2012002057A1 (es) Compuestos macrociclicos sustituidos, como inhibidores del virus de la hepatitis c; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende, utiles como agente antivirales.
PE20142456A1 (es) COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
PE20150200A1 (es) Formulacion de anticuerpos
EA201492011A1 (ru) Безводные фармацевтические составы для местного применения
PE20141821A1 (es) Composiciones herbicidas que contienen bentazon y el inhibidor als y el inhibidor accasa
EA201490806A1 (ru) Комбинированный состав двух противовирусных соединений
AR091604A1 (es) Potenciacion de autofagia o aumento de longevidad por administracion de urolitinas o precursores de las mismas, compuesto
CU24400B1 (es) Una composición que comprende 2,3-dihidroimidazo[1,2-c]quinazolinas sustituidas
DOP2016000253A (es) Nuevos compuestos
CL2013000714A1 (es) Compuestos derivados de lactamas sustituidas con piperidinilo, moduladores de gpr119; proceso de preparacion; composicion farmaceutica que los comprende; metodo de tratamiento; y uso del compuesto para tratar enfermedades tales como diabetes tipo 2, sindrome metabolico, dislipidemia, hipertension y esquizofrenia, entre otras.
PE20181352A1 (es) Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias
TR201902602T4 (tr) Yağ bazlı haşere öldürücü süspansiyon.
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
DOP2016000007A (es) Pirazolpiridinas sustituidas
UY35848A (es) Tienopirimidinas
DOP2015000137A (es) Dispersión sólida de un modulador selectivo de los receptores de progesterona
DOP2016000268A (es) Compuestos de azol amido–sustituidos como inhibidores de tnks1 y/o tnks2
AR100373A1 (es) Composición detergente líquida antimicrobiana para lavandería
BR112016001876A2 (pt) composto de benzoxaborol tricíclico, método de preparação e uso do mesmo
BR112014030720A8 (pt) composto, composição farmacêutica e usos de inibidores de fbx03
EA201500043A1 (ru) Лекарственная форма для продленного высвобождения действующих веществ
AR091739A1 (es) Composiciones y metodos para reducir el riesgo cardiometabolico
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt

Legal Events

Date Code Title Description
FD Application declared void or lapsed